Archem Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
- Paid Up Capital ₹ 1.45 M
- Company Age 38 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
About Archem Drugs
Archem Drugs Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 1986 and has a history of 38 years and two months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 1.45 M, as per Ministry of Corporate Affairs (MCA) records.
Satyendra Kumar and Amit Suman serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230BR1986PTC002468
-
Company No.
002468
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Nov 1986
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
What products or services does Archem Drugs Private Limited offer?
Archem Drugs Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Archem Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Suman
|
Director | 30-Mar-2012 | Current |
|
Satyendra Kumar
|
Director | 17-Nov-1986 | Current |
Financial Performance of Archem Drugs.
Archem Drugs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Archem Drugs?
In 2017, Archem Drugs had a promoter holding of 29.61% and a public holding of 70.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Archem Drugs?
Archem Drugs has a workforce of 7 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Archem Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Archem Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
